Login to Your Account



Other News To Note


Tuesday, August 28, 2012

• Meda AB, of Göteborg, Sweden, said the European Commission has granted marketing authorization for Zyclara (imiquimod 3.75% cream) for the treatment of actinic keratosis in the EU.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription